1016 related articles for article (PubMed ID: 23431463)
1. MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.
Sionov RV
ISRN Hematol; 2013; 2013():348212. PubMed ID: 23431463
[TBL] [Abstract][Full Text] [Related]
2. The effects of microRNAs on glucocorticoid responsiveness.
Wang H; Gou X; Jiang T; Ouyang J
J Cancer Res Clin Oncol; 2017 Jun; 143(6):1005-1011. PubMed ID: 28286901
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase networks regulating glucocorticoid-induced apoptosis of hematopoietic cancer cells: fundamental aspects and practical considerations.
Kfir-Erenfeld S; Sionov RV; Spokoini R; Cohen O; Yefenof E
Leuk Lymphoma; 2010 Nov; 51(11):1968-2005. PubMed ID: 20849387
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms regulating the susceptibility of hematopoietic malignancies to glucocorticoid-induced apoptosis.
Sionov RV; Spokoini R; Kfir-Erenfeld S; Cohen O; Yefenof E
Adv Cancer Res; 2008; 101():127-248. PubMed ID: 19055945
[TBL] [Abstract][Full Text] [Related]
5. Converting cell lines representing hematological malignancies from glucocorticoid-resistant to glucocorticoid-sensitive: signaling pathway interactions.
Garza AS; Miller AL; Johnson BH; Thompson EB
Leuk Res; 2009 May; 33(5):717-27. PubMed ID: 19012965
[TBL] [Abstract][Full Text] [Related]
6. A New Indole Derivative, LWX-473, Overcomes Glucocorticoid Resistance in Jurkat Cells by Activating Mediators of Apoptosis.
Song J; Yang K; Gajendran B; Varier KM; Li W; Liu Q; Rao Q; Hang Y; Shen X; Liu S; Huang L; Xu M; Li Y
Front Biosci (Landmark Ed); 2024 Apr; 29(4):163. PubMed ID: 38682179
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic alteration by DNA-demethylating treatment restores apoptotic response to glucocorticoids in dexamethasone-resistant human malignant lymphoid cells.
Miller AL; Geng C; Golovko G; Sharma M; Schwartz JR; Yan J; Sowers L; Widger WR; Fofanov Y; Vedeckis WV; Thompson EB
Cancer Cell Int; 2014; 14():35. PubMed ID: 24795534
[TBL] [Abstract][Full Text] [Related]
8. Stepping stones in the path of glucocorticoid-driven apoptosis of lymphoid cells.
Thompson EB
Acta Biochim Biophys Sin (Shanghai); 2008 Jul; 40(7):595-600. PubMed ID: 18604450
[TBL] [Abstract][Full Text] [Related]
9. Ectopic microRNA-150-5p transcription sensitizes glucocorticoid therapy response in MM1S multiple myeloma cells but fails to overcome hormone therapy resistance in MM1R cells.
Palagani A; Op de Beeck K; Naulaerts S; Diddens J; Sekhar Chirumamilla C; Van Camp G; Laukens K; Heyninck K; Gerlo S; Mestdagh P; Vandesompele J; Berghe WV
PLoS One; 2014; 9(12):e113842. PubMed ID: 25474406
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-124 regulates glucocorticoid sensitivity by targeting phosphodiesterase 4B in diffuse large B cell lymphoma.
Kim J; Jeong D; Nam J; Aung TN; Gim JA; Park KU; Kim SW
Gene; 2015 Mar; 558(1):173-80. PubMed ID: 25576220
[TBL] [Abstract][Full Text] [Related]
11. A conceptual view on glucocorticoid-lnduced apoptosis, cell cycle arrest and glucocorticoid resistance in lymphoblastic leukemia.
Renner K; Ausserlechner MJ; Kofler R
Curr Mol Med; 2003 Dec; 3(8):707-17. PubMed ID: 14682492
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance.
Schmidt S; Rainer J; Ploner C; Presul E; Riml S; Kofler R
Cell Death Differ; 2004 Jul; 11 Suppl 1():S45-55. PubMed ID: 15243581
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms contributing to glucocorticoid resistance in lymphoid malignancies.
Scheijen B
Cancer Drug Resist; 2019; 2(3):647-664. PubMed ID: 35582582
[TBL] [Abstract][Full Text] [Related]
14. Resistance to glucocorticoid-induced apoptosis in lymphoblastic leukemia.
Kofler R; Schmidt S; Kofler A; Ausserlechner MJ
J Endocrinol; 2003 Jul; 178(1):19-27. PubMed ID: 12844332
[TBL] [Abstract][Full Text] [Related]
15. Role for microRNAs in regulating glucocorticoid response and resistance in multiple myeloma.
Tessel MA; Benham AL; Krett NL; Rosen ST; Gunaratne PH
Horm Cancer; 2011 Jun; 2(3):182-9. PubMed ID: 21761344
[TBL] [Abstract][Full Text] [Related]
16. Akt2 mediates glucocorticoid resistance in lymphoid malignancies through FoxO3a/Bim axis and serves as a direct target for resistance reversal.
Xie M; Yang A; Ma J; Wu M; Xu H; Wu K; Jin Y; Xie Y
Cell Death Dis; 2019 Jan; 9(10):1013. PubMed ID: 30598523
[TBL] [Abstract][Full Text] [Related]
17. The role of microRNAs in glucocorticoid action.
Clayton SA; Jones SW; Kurowska-Stolarska M; Clark AR
J Biol Chem; 2018 Feb; 293(6):1865-1874. PubMed ID: 29301941
[TBL] [Abstract][Full Text] [Related]
18. Effect of combining glucocorticoids with Compound A on glucocorticoid receptor responsiveness in lymphoid malignancies.
Clarisse D; Van Wesemael K; Tavernier J; Offner F; Beck IM; De Bosscher K
PLoS One; 2018; 13(5):e0197000. PubMed ID: 29738549
[TBL] [Abstract][Full Text] [Related]
19. Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression.
Geley S; Hartmann BL; Hala M; Strasser-Wozak EM; Kapelari K; Kofler R
Cancer Res; 1996 Nov; 56(21):5033-8. PubMed ID: 8895760
[TBL] [Abstract][Full Text] [Related]
20. Eosinophil resistance to glucocorticoid-induced apoptosis is mediated by the transcription factor NFIL3.
Pazdrak K; Moon Y; Straub C; Stafford S; Kurosky A
Apoptosis; 2016 Apr; 21(4):421-31. PubMed ID: 26880402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
